Trials / Unknown
UnknownNCT05302726
Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
Betydning af Eksogent østrogen på Serum Kortisol Under Synacthen-stimulering Hos Hypogonade Kvinder Med Binyrebarkinsufficiens
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to investigate impact of exogenous estrogens on cotisol Levels during synacthen stimulation in female hypogonal patients on estrogen substitution. Both patients with and withour adrenal insufficiency will be studied
Detailed description
The aim is to investigate impact of exogenous estrogens on cotisol levels during synacthen stimulation in female hypogonal patients on estrogen substitution. Both patients with and without adrenal insufficiency will be studied . All patients (inclusion criteria age 18-50 years, BMI \<35) will be followed for 6 months and have 3 synacthentests performed: One on transdermal estrogen (minimum 3 months), one on oral estrogens (min 3 months) and one without estrogen substitution for at least 3 months. Primary endpoint is change in serum cortisol 30 minutes after synacthen stimulation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Estrogen | Transdermal and oral estrogen both as substitution therapy |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-12-31
- Completion
- 2023-06-01
- First posted
- 2022-03-31
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05302726. Inclusion in this directory is not an endorsement.